Bucharest Stock Exchange (BVB) announced that the shares of Antibiotice, a Romanian manufacturer of generic drugs will be included in the indices of the global index provider MSCI, starting with the 1st trading day of December.
BVB stated in a press release on Wednesday, that ATB will be included in the MSCI Frontier IMI and MSCI Romania IMI (Investable Market Indices) indices, in the Small Cap category. ATB’s inclusion in these indices was part of the November quarterly index review of the global index provider MSCI.
With the inclusion of ATB in these indices, Romania’s presence increases from 22 to 23 companies in the MSCI Frontier IMI and MSCI Romania IMI indices. These indices comprise companies in the Small Cap, Mid Cap and Large Cap size categories.
In the MSCI Frontier Markets indices, Romania is represented also by Banca Transilvania, BRD Groupe Societe Generale, Hidroelectrica, Nuclearelectrica, OMV Petrom, Romgaz, Electrica, MedLife, One United Properties, Teraplast, Transelectrica, Transgaz, Aquila Part Prod, Arobs Transilvania Software, Bittnet Systems, Bursa de Valori Bucuresti, Conpet, Purcari Wineries, Safetech Innovations, Simtel Team, Sphera Franchise Group, TTS Transport Trade Services.
Romania is classified as an Emerging Market by the global indices provider FTSE Russell, being represented by 13 companies: Banca Transilvania, Hidroelectrica, MedLife, Nuclearelectrica, OMV Petrom, One United Properties, Teraplast, Aquila Part Prod, Bittnet Systems, Bursa de Valori Bucuresti, Conpet, Purcari Wineries, Sphera Franchise Group.